Rituximab is more effective than second anti-TNF therapy in rheumatoid arthritis patients and previous TNFα blocker failure
Joern Kekow,1 Ulf Mueller-Ladner,2 Hendrik Schulze-Koops31Clinic of Rheumatology and Orthopedics, Otto-von-Guericke University of Magdeburg, Vogelsang-Gommern; 2Department of Rheumatology and Clinical Immunology, Kerckhoff Clinic, Bad Nauheim; 3Division of Rheumatology, University of Munich, Munich,...
Enregistré dans:
Auteurs principaux: | Kekow J, Mueller-Ladner U, Schulze-Koops H |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2012
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/37d8e8927a8e4ddeb95b0c7b9042a8bd |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Cost-effectiveness of routine measuring of serum drug concentrations and anti-drug antibodies in treatment of rheumatoid arthritis patients with TNF-α blockers
par: Laine J, et autres
Publié: (2016) -
Prevention of bone mineral density loss in patients with rheumatoid arthritis treated with anti-TNFα therapy
par: Hubert Marotte, et autres
Publié: (2008) -
TNF, SOLUBLE RECEPTORS AND AUTOANTIBODIES TO TNF OF PATIENTS WITH RHEUMATOID ARTHRITIS AND HEALTHY DONORS
par: E. A. Golikova, et autres
Publié: (2012) -
Regression of macular edema secondary to branch retinal vein occlusion during anti-TNF-α therapy for rheumatoid arthritis
par: Shu Kachi, et autres
Publié: (2010) -
Anti-TNF-alpha agents and endothelial function in rheumatoid arthritis: a systematic review and meta-analysis
par: Francesco Ursini, et autres
Publié: (2017)